How Quantum Computing System Size and Performance Enhances the Drug Discovery Process for KRAS Mutants

This study discusses the role of quantum computing in the drug discovery process for KRAS mutants and how larger qubit counts and increases in circuit depth can enhance the process.Increasing system size may offer improvements in the coming years.Specifically, as quantum computing enters the fault-tolerant era, algorithms requiring error-correction due to their long runtimes and sensitivity to noise can be used.By increasing the number of high-fidelity operations compared to today's error-prone quantum computers, fault-tolerant systems will enable new classes of more capable algorithms and enhanced discovery of KRAS inhibitors.Lowering maintenance costs and increasing accessibility of quantum computers are necessary for a larger population to be able to make more rapid advancements in the field.